Anterix (ATEX) Price to Sales (2015 - 2026)

Anterix (ATEX) has reported Price to Sales for 12 consecutive years, with 1027.84 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 203.93% year-over-year to 1027.84; the trailing twelve-month figure through Jun 2026 stood at 285.83 (up 253.09% YoY), and the FY2026 full-year result was 111.11, down 1.63% from the prior year.
• Price to Sales grew to 1027.84 in Q2 2026 per ATEX's latest filing, from 368.92 in the prior quarter.
• Across five years, Price to Sales topped out at 3176.29 in Q1 2022 and bottomed at 258.79 in Q3 2025.
• Historically, Price to Sales has averaged 880.71 across 5 years, with a median of 491.33 in 2024.
• The sharpest annual moves came in 2022 and 2026: Price to Sales plunged 72.17% in 2022, then jumped 203.93% in 2026.
• Over 5 years, Price to Sales stood at 1050.19 in 2022, then slumped by 53.68% to 486.41 in 2023, then retreated by 25.16% to 364.02 in 2024, then retreated by 28.59% to 259.93 in 2025, then jumped by 295.43% to 1027.84 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 1027.84, 368.92, and 259.93 for Q2 2026, Q1 2026, and Q4 2025 respectively.